Copyright Reports & Markets. All rights reserved.

Global Human Microbiome Therapeutic Drugs Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Human Microbiome Therapeutic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 FMT
    • 1.2.3 Microbiome Drugs
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Human Microbiome Therapeutic Drugs Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Stomach
    • 1.3.3 Oral
    • 1.3.4 Respiratory Tract
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Human Microbiome Therapeutic Drugs Market Perspective (2016-2027)
  • 2.2 Human Microbiome Therapeutic Drugs Growth Trends by Regions
    • 2.2.1 Human Microbiome Therapeutic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Human Microbiome Therapeutic Drugs Historic Market Share by Regions (2016-2021)
    • 2.2.3 Human Microbiome Therapeutic Drugs Forecasted Market Size by Regions (2022-2027)
  • 2.3 Human Microbiome Therapeutic Drugs Industry Dynamic
    • 2.3.1 Human Microbiome Therapeutic Drugs Market Trends
    • 2.3.2 Human Microbiome Therapeutic Drugs Market Drivers
    • 2.3.3 Human Microbiome Therapeutic Drugs Market Challenges
    • 2.3.4 Human Microbiome Therapeutic Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Human Microbiome Therapeutic Drugs Players by Revenue
    • 3.1.1 Global Top Human Microbiome Therapeutic Drugs Players by Revenue (2016-2021)
    • 3.1.2 Global Human Microbiome Therapeutic Drugs Revenue Market Share by Players (2016-2021)
  • 3.2 Global Human Microbiome Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Human Microbiome Therapeutic Drugs Revenue
  • 3.4 Global Human Microbiome Therapeutic Drugs Market Concentration Ratio
    • 3.4.1 Global Human Microbiome Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutic Drugs Revenue in 2020
  • 3.5 Human Microbiome Therapeutic Drugs Key Players Head office and Area Served
  • 3.6 Key Players Human Microbiome Therapeutic Drugs Product Solution and Service
  • 3.7 Date of Enter into Human Microbiome Therapeutic Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Human Microbiome Therapeutic Drugs Breakdown Data by Type

  • 4.1 Global Human Microbiome Therapeutic Drugs Historic Market Size by Type (2016-2021)
  • 4.2 Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Type (2022-2027)

5 Human Microbiome Therapeutic Drugs Breakdown Data by Application

  • 5.1 Global Human Microbiome Therapeutic Drugs Historic Market Size by Application (2016-2021)
  • 5.2 Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Human Microbiome Therapeutic Drugs Market Size (2016-2027)
  • 6.2 North America Human Microbiome Therapeutic Drugs Market Size by Type
    • 6.2.1 North America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
    • 6.2.2 North America Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
    • 6.2.3 North America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
  • 6.3 North America Human Microbiome Therapeutic Drugs Market Size by Application
    • 6.3.1 North America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
    • 6.3.2 North America Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
    • 6.3.3 North America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
  • 6.4 North America Human Microbiome Therapeutic Drugs Market Size by Country
    • 6.4.1 North America Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021)
    • 6.4.2 North America Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Human Microbiome Therapeutic Drugs Market Size (2016-2027)
  • 7.2 Europe Human Microbiome Therapeutic Drugs Market Size by Type
    • 7.2.1 Europe Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
    • 7.2.2 Europe Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
    • 7.2.3 Europe Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
  • 7.3 Europe Human Microbiome Therapeutic Drugs Market Size by Application
    • 7.3.1 Europe Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
    • 7.3.2 Europe Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
    • 7.3.3 Europe Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
  • 7.4 Europe Human Microbiome Therapeutic Drugs Market Size by Country
    • 7.4.1 Europe Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021)
    • 7.4.2 Europe Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size (2016-2027)
  • 8.2 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type
    • 8.2.1 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application
    • 8.3.1 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region
    • 8.4.1 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Human Microbiome Therapeutic Drugs Market Size (2016-2027)
  • 9.2 Latin America Human Microbiome Therapeutic Drugs Market Size by Type
    • 9.2.1 Latin America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
    • 9.2.2 Latin America Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
    • 9.2.3 Latin America Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
  • 9.3 Latin America Human Microbiome Therapeutic Drugs Market Size by Application
    • 9.3.1 Latin America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
    • 9.3.2 Latin America Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
    • 9.3.3 Latin America Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
  • 9.4 Latin America Human Microbiome Therapeutic Drugs Market Size by Country
    • 9.4.1 Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021)
    • 9.4.2 Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size (2016-2027)
  • 10.2 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type
    • 10.2.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application
    • 10.3.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country
    • 10.4.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Rebiotix
    • 11.1.1 Rebiotix Company Details
    • 11.1.2 Rebiotix Business Overview
    • 11.1.3 Rebiotix Human Microbiome Therapeutic Drugs Introduction
    • 11.1.4 Rebiotix Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
    • 11.1.5 Rebiotix Recent Development
  • 11.2 Seres Therapeutics
    • 11.2.1 Seres Therapeutics Company Details
    • 11.2.2 Seres Therapeutics Business Overview
    • 11.2.3 Seres Therapeutics Human Microbiome Therapeutic Drugs Introduction
    • 11.2.4 Seres Therapeutics Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
    • 11.2.5 Seres Therapeutics Recent Development
  • 11.3 Vedanta Biosciences
    • 11.3.1 Vedanta Biosciences Company Details
    • 11.3.2 Vedanta Biosciences Business Overview
    • 11.3.3 Vedanta Biosciences Human Microbiome Therapeutic Drugs Introduction
    • 11.3.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
    • 11.3.5 Vedanta Biosciences Recent Development
  • 11.4 Bristol-Myers Squibb
    • 11.4.1 Bristol-Myers Squibb Company Details
    • 11.4.2 Bristol-Myers Squibb Business Overview
    • 11.4.3 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Introduction
    • 11.4.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
    • 11.4.5 Bristol-Myers Squibb Recent Development
  • 11.5 Johnson and Johnson
    • 11.5.1 Johnson and Johnson Company Details
    • 11.5.2 Johnson and Johnson Business Overview
    • 11.5.3 Johnson and Johnson Human Microbiome Therapeutic Drugs Introduction
    • 11.5.4 Johnson and Johnson Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
    • 11.5.5 Johnson and Johnson Recent Development
  • 11.6 Takeda
    • 11.6.1 Takeda Company Details
    • 11.6.2 Takeda Business Overview
    • 11.6.3 Takeda Human Microbiome Therapeutic Drugs Introduction
    • 11.6.4 Takeda Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
    • 11.6.5 Takeda Recent Development
  • 11.7 ENTEROME Bioscience
    • 11.7.1 ENTEROME Bioscience Company Details
    • 11.7.2 ENTEROME Bioscience Business Overview
    • 11.7.3 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Introduction
    • 11.7.4 ENTEROME Bioscience Revenue in Human Microbiome Therapeutic Drugs Business (2016-2021)
    • 11.7.5 ENTEROME Bioscience Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Human Microbiome Therapeutic Drugs Scope and Market Size
    Human Microbiome Therapeutic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Microbiome Therapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    FMT
    Microbiome Drugs
    Others

    Segment by Application
    Stomach
    Oral
    Respiratory Tract
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Rebiotix
    Seres Therapeutics
    Vedanta Biosciences
    Bristol-Myers Squibb
    Johnson and Johnson
    Takeda
    ENTEROME Bioscience

    Buy now